Proceedings of the 1st biannual bridging the gaps in lung cancer conference
Lung cancer is the leading cause of cancer death in the US and globally. The mortality from lung cancer has been declining, due to a reduction in incidence and advances in treatment. Although recent success in developing targeted and immunotherapies for lung cancer has benefitted patients, it has also expanded the complexity of potential treatment options for health care providers. To aid in reducing such complexity, experts in oncology convened a conference (Bridging the Gaps in Lung Cancer) to identify current knowledge gaps and controversies in the diagnosis, treatment, and outcomes of various lung cancer scenarios, as described here. Such scenarios relate to biomarkers and testing in lung cancer, small cell lung cancer, EGFR mutations and targeted therapy in non-small cell lung cancer (NSCLC), early-stage NSCLC, KRAS/BRAF/MET and other genomic alterations in NSCLC, and immunotherapy in advanced NSCLC.
Authors
- Ravi Salgia (ORCID: https://orcid.org/0000-0001-9643-7626)
- Benjamin Levy (ORCID: https://orcid.org/0009-0005-2331-8542)
- Russell Miller (ORCID: https://orcid.org/0000-0003-0268-1391)
- Joshua K. Sabari (ORCID: https://orcid.org/0000-0002-1556-1543)
- Puneeth Iyengar (ORCID: https://orcid.org/0000-0003-3740-7915)
- Shirish M. Gadgeel (ORCID: https://orcid.org/0000-0001-5240-3811)
- Erminia Massarelli (ORCID: https://orcid.org/0000-0001-7798-7286)
- Lyudmila Bazhenova
- Hatim Husain (ORCID: https://orcid.org/0000-0003-4228-0963)
- Heather A. Wakelee (ORCID: https://orcid.org/0000-0003-1136-980X)
- Narjust Florez (ORCID: https://orcid.org/0009-0004-0806-6722)
- Percy Lee
- Jyoti Malhotra (ORCID: https://orcid.org/0000-0001-8586-0234)
- Brendon M. Stiles (ORCID: https://orcid.org/0000-0002-4047-9787)
- Jacob M. Sands (ORCID: https://orcid.org/0000-0003-4663-7464)
- Matthew A. Gubens (ORCID: https://orcid.org/0000-0002-6482-1954)
- C. Patrick (ORCID: https://orcid.org/0000-0002-8425-1223)
- Tina Cascone (ORCID: https://orcid.org/0000-0003-3008-5407)
- Solange Peters (ORCID: https://orcid.org/0000-0002-0412-7143)
- Michelle Afkhami (ORCID: https://orcid.org/0000-0001-5830-6158)
- Sandip Pravin Patel (ORCID: https://orcid.org/0000-0002-8387-4840)
- Jorge J. Nieva (ORCID: https://orcid.org/0000-0003-1605-4719)
- Fred R. Hirsch (ORCID: https://orcid.org/0000-0002-6885-1894)
- Leah M. Backhus (ORCID: https://orcid.org/0000-0002-4553-1003)
- Edward Kim (ORCID: https://orcid.org/0000-0002-7715-4054)
Institutions
- University of Southern California (US)
- Albert Einstein College of Medicine (US)
- City Of Hope National Medical Center (US)
- Mount Sinai Health System (US)
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Harvard University (US)
- Johns Hopkins University (US)
- Henry Ford Health System (US)
- Palo Alto University (US)
- University of California, San Francisco (US)
- Henry Ford Hospital (US)
- University of California San Diego (US)
- NYU Langone Health (US)
- University of California, Irvine Medical Center (US)
- City of Hope (US)
- University of California San Francisco Medical Center (US)
- USC Norris Comprehensive Cancer Center (US)
- Dana-Farber Cancer Institute (US)
- Dana-Farber/Harvard Cancer Center (US)
- Sidney Kimmel Comprehensive Cancer Center (US)
- Stanford Cancer Institute
- NYU Langone’s Laura and Isaac Perlmutter Cancer Center
- Penn State Milton S. Hershey Medical Center (US)
- Stanford University (US)
- University of Lausanne (CH)
Publication Details
- Journal
- The Oncologist
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1093/oncolo/oyae228
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.42